About Morphoceuticals
Morphoceuticals is a company based in Marblehead (United States) founded in 2020 by David Kaplan and Michael Levin.. Morphoceuticals has raised $13.32 million across 2 funding rounds from investors including Juvenescence and Prime Movers Lab. Morphoceuticals offers products and services including Bioelectrome Atlas. Morphoceuticals operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter Marblehead, United States
- Founders David Kaplan, Michael Levin
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Morphoceuticals, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.32 M (USD)
in 2 rounds
-
Latest Funding Round
$3.5 M (USD), Seed
Sep 23, 2024
-
Investors
Juvenescence
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Morphoceuticals
Morphoceuticals offers a comprehensive portfolio of products and services, including Bioelectrome Atlas. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-powered tool to map bioelectric networks for tissue regeneration and disease treatment
Unlock access to complete
Unlock access to complete
Leadership Team
3 people
Founder Team
2 people
Product Management Team
1 people
Translational Team
1 people
Unlock access to complete
Funding Insights of Morphoceuticals
Morphoceuticals has successfully raised a total of $13.32M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $3.5 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $3.5M
-
First Round
First Round
(23 Jan 2023)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Seed - Morphoceuticals | Valuation |
investors |
|
| Jan, 2023 | Amount | Seed - Morphoceuticals | Valuation | Prime Movers Lab |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Morphoceuticals
Morphoceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Juvenescence and Prime Movers Lab. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm funding breakthrough scientific startups and innovative sectors worldwide.
|
Founded Year | Domain | Location | |
|
Provider of proprietary ketone ester-based therapeutic drink for age-related disorders and metabolic health
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Morphoceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Morphoceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Morphoceuticals Comparisons
Competitors of Morphoceuticals
Morphoceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Morphoceuticals
When was Morphoceuticals founded?
Morphoceuticals was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Where is Morphoceuticals located?
Morphoceuticals is headquartered in Marblehead, United States. It is registered at Marblehead, Massachusetts, United States.
Is Morphoceuticals a funded company?
Morphoceuticals is a funded company, having raised a total of $13.32M across 2 funding rounds to date. The company's 1st funding round was a Seed of $9.82M, raised on Jan 23, 2023.
What does Morphoceuticals do?
Ion-channel drugs are developed by Morphoceuticals, founded in 2020 and based in Marblehead, United States, within the biotechnology sector. Bioelectric signaling is targeted to reprogram cellular biology, enabling regeneration of tissues and organs, including the brain. Operations focus on applications such as amputation stump health, limb regeneration, and organogenesis, with an emphasis on treating complex health conditions through native bioelectric mechanisms.
Who are the top competitors of Morphoceuticals?
Morphoceuticals's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does Morphoceuticals offer?
Morphoceuticals offers Bioelectrome Atlas.
Who are Morphoceuticals's investors?
Morphoceuticals has 2 investors. Key investors include Juvenescence, and Prime Movers Lab.